EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Persistent Campylobacter jejuni enterocolitis after CAR T-cell therapy in a patient with hypogammaglobulinemic follicular lymphoma

Dina Oulkadi iD, Florian Van Oers iD, Leen Vanden Driessche, Sarah Vandamme iD, Veerle Matheeussen iD, Célestin Mairesse iD, Delphine Martiny iD, Sébastien Anguille iD, Thomas Demuyser iD

ASM Case Reports · 03.11.2026 · 2 (6)

DOI: 10.1128/asmcr.00047-26 ↗

Kurz gefasst

Fallbericht in der Zeitschrift ASM Case Reports, erschienen am 03.11.2026. Verfasst von Dina Oulkadi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Microbiology, Antwerp University Hospital, Edegem, Belgium. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Campylobacter jejuni is a leading cause of bacterial gastroenteritis worldwide and typically results in self-limiting enterocolitis in immunocompetent individuals. In contrast, immunocompromised patients are at risk for severe, recurrent, or persistent infection. Chimeric antigen receptor (CAR) T-cell therapy targeting CD19 induces prolonged B-cell aplasia and hypogammaglobulinemia, predisposing patients to atypical infections. We report the first case of persistent and disseminated C. jejuni infection following CD19-directed CAR T-cell therapy, confirmed by whole-genome sequencing. Case Summary A 68-year-old man with relapsed follicular lymphoma underwent autologous CD19-directed CAR T-cell therapy and achieved complete remission. Pre-existing hypogammaglobulinemia worsened after treatment. Eighteen months later, he developed recurrent bacteremia and chronic enterocolitis caused by C. jejuni . Over the following year, he experienced severe watery diarrhea, 20 kg weight loss, and disseminated infection with a prosthetic hip abscess. More than 10 stool cultures remained positive despite multiple antibiotic regimens and two fecal microbiota transplantations. Whole-genome sequencing demonstrated a single clonal strain with minimal variation, confirming persistent infection rather than reinfection. Microbiological clearance was achieved after 8 weeks of oral gentamicin, followed by 2 weeks of intravenous meropenem and azithromycin, with sustained negative cultures and PCR.

Conclusion

Persistent and disseminated C. jejuni infection can occur in patients with hypogammaglobulinemia after CD19-directed CAR T-cell therapy. Whole-genome sequencing may help distinguish persistence from reinfection. Standard immunoglobulin replacement may be insufficient due to limited IgA and IgM, and prolonged combination antimicrobial therapy may be required for durable remission.

Schlagwörter

Stichwörter der Autor:innen

CAR T-cell therapyCampylobacter jejunihypogammaglobulinemiapersistent infection

Autor:innen und Institutionen

  • Department of Clinical Microbiology, Antwerp University Hospital, Edegem, Belgium.
  • Division of Hematology and Center for Cell Therapy & Regenerative Medicine, Antwerp University Hospital, Edegem, Belgium.
  • Faculty of Medicine and Health Sciences, Laboratory of Experimental Hematology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.
  • Department of Microbiology, Laboratoire Hospitalier Universitaire de Bruxelles-Universitair Laboratorium Brussel (LHUB-ULB), Brussels, Belgium.
  • Belgian National Reference Centre for Campylobacter (LHUB-ULB), Brussels, Belgium.
  • Department of Bioscience Engineering, Laboratory of Applied Microbiology and Biotechnology, University of Antwerp, Antwerp, Belgium.

ORCID-Profile: Dina Oulkadi, Florian Van Oers, Sarah Vandamme, Veerle Matheeussen, Célestin Mairesse, Delphine Martiny, Sébastien Anguille, Thomas Demuyser

Zitieren

APA

Oulkadi, D., Van Oers, F., Vanden Driessche, L., Vandamme, S., Matheeussen, V., Mairesse, C., Martiny, D., Anguille, S., & Demuyser, T. (2026). Persistent Campylobacter jejuni enterocolitis after CAR T-cell therapy in a patient with hypogammaglobulinemic follicular lymphoma. ASM Case Reports, 2(6). https://doi.org/10.1128/asmcr.00047-26

Vancouver

Oulkadi D, Van Oers F, Vanden Driessche L, Vandamme S, Matheeussen V, Mairesse C, et al. Persistent Campylobacter jejuni enterocolitis after CAR T-cell therapy in a patient with hypogammaglobulinemic follicular lymphoma. ASM Case Reports. 2026;2(6). doi:10.1128/asmcr.00047-26

BibTeX
@article{Oulkadi2026,
  author = {Oulkadi, Dina and Van Oers, Florian and Vanden Driessche, Leen and Vandamme, Sarah and Matheeussen, Veerle and Mairesse, Célestin and Martiny, Delphine and Anguille, Sébastien and Demuyser, Thomas},
  title = {Persistent Campylobacter jejuni enterocolitis after CAR T-cell therapy in a patient with hypogammaglobulinemic follicular lymphoma},
  journal = {ASM Case Reports},
  year = {2026},
  volume = {2},
  number = {6},
  doi = {10.1128/asmcr.00047-26}
}
Kostenlos starten →